Comparative Effects of Variable Pressure Support, NAVA and PAV

Comparative Effects of Variable Pressure Support, Neurally Adjusted Ventilatory Assist (NAVA) and Proportional Assist Ventilation (PAV) on the Variability of the Breathing Pattern and on Patient Ventilator Interaction

Experimental animal data suggest that increasing breathing pattern variability in mechanical ventilation could be beneficial. Variable ventilation can be induced through the following modes: Neurally Adjust Ventilatory Assist (NAVA), Proportional Assist Ventilation (PAV) and Variable-Pressure Support Ventilation (V-PSV). These modes have not yet been compared to each other. Pilot observations in our department suggest a feasibility in patients.

The objectives of the study are to compare the impact of PSV, NAVA, PAV and V-PSV on the variability of the breathing pattern, patient-ventilator asynchrony, risk of lung overdistension, gas exchange, and repartition of ventilation.

Study Overview

Status

Completed

Conditions

Detailed Description

Cross-over, prospective, randomized controlled monocentric trial . Patients on pressure support ventilation will be ventilated with PSV, NAVA, PAV, and V-PSV (in a randomized sequence).

In each mode the level of assistance will be set to achieve a similar tidal volume of 6-8 ml/kg.

The following data will be measured and recorded: airway flow and pressure, electrical activity of the diaphragm (EAdi), blood gases, electrical impedance tomography, end tidal partial pressure in carbon dioxide (PEtCO2).

Will be calculated: the coefficient of variation (CV, standard deviation (SD)/mean) of the peak pressure (Ppeak), EAdi and of the main descriptors of the breathing pattern, the prevalence of the main patient-ventilator asynchronies, the prevalence of tidal volume (VT) >10ml/kg, ventrodorsal repartition of ventilation and inhomogeneity index, dead space

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75013
        • Service de Pneumologie et Réanimation Médicale, Groupe Hospitalier Pitié Salpêtrière

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient on mechanical ventilation for >48 h
  • estimated duration of mechanical ventilation >24h
  • hemodynamic stability

Exclusion Criteria:

  • pregnancy
  • impossibility to insert an EAdi catheter
  • neuromuscular disease, phrenic nerve lesions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PSV, PAV, NAVA, Variable-PSV
This is a crossover study in which each patient will be ventilated in the following modes of mechanical ventilation: Pressure Support Ventilation (PSV), Neurally Adjusted Ventilator Assist (NAVA), Proportional assist ventilation (NAVA) and variable Pressure Support Ventilation (Variable-PSV), in a randomised order.
Each patient enrolled in the study will be ventilated in all the following modes: PSV, NAVA, PAV and variable PSV

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coefficient of variation of the tidal volume (VT)
Time Frame: 1 hour
Coefficient of variation (standard deviation/mean) of the tidal volume (VT)
1 hour
Coefficient of variation of the respiratory rate (RR)
Time Frame: 1 hour
Coefficient of variation (standard deviation/mean) of the respiratory rate (RR)
1 hour
Coefficient of variation of the inspiratory time (Ti)
Time Frame: 1 hour
Coefficient of variation (standard deviation/mean) of the inspiratory time (Ti)
1 hour
Coefficient of variation of the electrical activity of the diaphragm (EAdi)
Time Frame: 1 hour
Coefficient of variation (standard deviation/mean) of the electrical activity of the diaphragm (EAdi)
1 hour
Coefficient of variation of the maximal inspiratory pressure (Ppeak)
Time Frame: 1 hour
Coefficient of variation (standard deviation/mean) of the maximal inspiratory pressure (Ppeak)
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient ventilator asynchrony
Time Frame: 1 hour
asynchrony index (composite outcome, that includes double triggering, auto triggering and ineffective efforts) )
1 hour
Safety from lung overdistension, assessed by the proportion of tidal volumes (VT) >10 ml/kg
Time Frame: 1 hour
1 hour
Gas exchanges
Time Frame: 6 hours
Ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2), arterial carbon dioxide pressure (PaCO2)
6 hours
Repartition of ventilation measured by electrical impedance tomography
Time Frame: 6 hours
6 hours
Dead space to tidal volume ratio (Vd/Vt)
Time Frame: 6 hours
Vd/Vd, is a ratio between two volumes
6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Alexandre Demoule, MD, PHD, Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

June 12, 2015

First Submitted That Met QC Criteria

July 14, 2015

First Posted (Estimate)

July 16, 2015

Study Record Updates

Last Update Posted (Estimate)

December 29, 2015

Last Update Submitted That Met QC Criteria

December 28, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on PSV, NAVA, PAV, Variable-PSV

3
Subscribe